STOCK TITAN

TELA Bio to Announce Third Quarter 2021 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA) announced it will report its third quarter 2021 financial results on November 10, 2021, followed by a conference call at 4:30 p.m. ET. The company focuses on developing innovative tissue reinforcement materials for soft tissue reconstruction. Its products aim to improve clinical outcomes while minimizing the use of permanent synthetic materials. Investors can access the conference call by dialing specific numbers or through a webcast available on TELA's investor website.

Positive
  • TELA Bio focuses on innovative solutions in soft tissue reconstruction.
  • Upcoming Q3 results announcement could provide insights into financial performance.
Negative
  • None.

MALVERN, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the company will report third quarter 2021 financial results on Wednesday, November 10, 2021. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details
The conference call can be accessed by dialing 855-548-1219 for participants in the U.S. or Canada and 409-217-8881 for international callers, using conference ID 8535689. A live and archived webcast of the event can be accessed via the Events & Presentations page of the investor section of TELA's website.

About TELA Bio, Inc.
TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. For more information, visit www.telabio.com.

Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com


FAQ

When will TELA Bio announce its third-quarter results for 2021?

TELA Bio will report its third quarter 2021 financial results on November 10, 2021.

What time is TELA's conference call to discuss Q3 results?

The conference call will take place at 4:30 p.m. ET on November 10, 2021.

How can I access TELA Bio's Q3 2021 conference call?

You can access the call by dialing 855-548-1219 in the U.S. or Canada, or 409-217-8881 internationally, using conference ID 8535689.

What products does TELA Bio offer?

TELA Bio offers innovative tissue reinforcement materials, including OviTex® and OviTex PRS Reinforced Tissue Matrix.

TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

112.65M
33.31M
7.32%
51.7%
0.85%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN